BRITISH JOURNAL OF OPHTHALMOLOGY

Scope & Guideline

Empowering Ocular Science: Where Innovation Meets Insight

Introduction

Delve into the academic richness of BRITISH JOURNAL OF OPHTHALMOLOGY with our guidelines, detailing its aims and scope. Our resource identifies emerging and trending topics paving the way for new academic progress. We also provide insights into declining or waning topics, helping you stay informed about changing research landscapes. Evaluate highly cited topics and recent publications within these guidelines to align your work with influential scholarly trends.
LanguageEnglish
ISSN0007-1161
PublisherBMJ PUBLISHING GROUP
Support Open AccessNo
CountryUnited Kingdom
TypeJournal
Convergefrom 1941 to 2024
AbbreviationBRIT J OPHTHALMOL / Br. J. Ophthalmol.
Frequency12 issues/year
Time To First Decision-
Time To Acceptance-
Acceptance Rate-
Home Page-
AddressBRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND

Aims and Scopes

The British Journal of Ophthalmology focuses on advancing the field of ophthalmology through high-quality research that encompasses a wide array of topics related to eye health and diseases. Its scope includes clinical studies, experimental research, and innovative methodologies that enhance the understanding and treatment of ocular conditions.
  1. Clinical Ophthalmology:
    The journal emphasizes studies that investigate clinical outcomes, treatment effectiveness, and patient management strategies for various ocular diseases, including glaucoma, diabetic retinopathy, and age-related macular degeneration.
  2. Innovative Surgical Techniques:
    Research on novel surgical techniques and technologies, such as advanced cataract surgery methods, retinal detachment repair techniques, and the use of intraocular devices, is a core focus area.
  3. Genetics and Molecular Ophthalmology:
    There is a significant emphasis on genetic studies related to inherited retinal diseases, providing insights into gene mutations and their implications for patient care.
  4. Artificial Intelligence in Ophthalmology:
    The journal explores the integration of artificial intelligence and machine learning in diagnosing and managing ocular diseases, reflecting a growing trend towards technological innovation in the field.
  5. Epidemiology and Public Health:
    Epidemiological studies that assess the prevalence, risk factors, and societal impact of ocular diseases, particularly in diverse populations, are also a significant focus.
The British Journal of Ophthalmology is currently witnessing emerging trends that reflect advancements in technology and a deeper understanding of ocular health. These themes are gaining traction and are likely to shape future research directions.
  1. Telemedicine and Remote Patient Monitoring:
    The rise of telemedicine in ophthalmology is increasingly evident, with studies exploring its effectiveness in managing patient care and screening for ocular diseases, particularly in the context of the COVID-19 pandemic.
  2. Myopia Control Strategies:
    There is a notable increase in research focusing on myopia control, including the efficacy of various interventions such as atropine, orthokeratology, and the impact of environmental factors, reflecting a growing public health concern.
  3. Artificial Intelligence Applications:
    The application of artificial intelligence in diagnosing and managing ocular diseases is a rapidly growing field, with numerous studies developing algorithms for automated detection of conditions such as diabetic retinopathy and glaucoma.
  4. Ocular Surface Disease and Dry Eye Research:
    Research on ocular surface diseases, particularly dry eye syndrome, is gaining prominence, focusing on new treatment modalities and the impact of systemic health on ocular surface integrity.
  5. Genetic and Genomic Studies:
    An increasing trend towards understanding the genetic basis of ocular diseases is evident, with studies investigating gene therapy and genetic predispositions to conditions like retinitis pigmentosa and age-related macular degeneration.

Declining or Waning

While the British Journal of Ophthalmology continues to publish a wide range of research, some themes appear to be declining in prominence over recent years. This may be reflective of shifting research priorities or advancements in understanding certain areas.
  1. Traditional Pharmacological Studies:
    There seems to be a decreasing focus on traditional pharmacological studies comparing established treatments for common ocular conditions, as newer therapeutic approaches and technologies gain traction.
  2. Basic Science Research:
    Research that primarily focuses on basic science without direct clinical application appears to be waning, as there is a stronger push towards translational studies that connect laboratory findings with clinical practice.
  3. Longitudinal Studies on Rare Ocular Conditions:
    The frequency of longitudinal studies focusing on rare ocular diseases has declined, possibly due to the challenges in recruitment and the limited patient populations available for such research.

Similar Journals

International Journal of Retina and Vitreous

Advancing ocular health through innovative research.
Publisher: BMCISSN: Frequency: 1 issue/year

The International Journal of Retina and Vitreous, published by BMC, stands as a premier open-access platform dedicated to advancing the field of ophthalmology, specifically focusing on retina and vitreous research. Established in 2015, this journal has swiftly positioned itself within the academic community, achieving a commendable Q2 category ranking in Ophthalmology for 2023, and ranks #49 out of 137 in Scopus for Medicine - Ophthalmology, indicating its growing influence and reach within the scientific landscape. The journal is committed to disseminating high-quality research, reviews, and clinical insights that explore innovations, challenges, and breakthroughs in ocular health. With the goal of fostering knowledge exchange among researchers, practitioners, and students, the International Journal of Retina and Vitreous promotes an open-access model, ensuring that vital findings are readily available to a global audience. This journal not only serves as a vital resource for advancing the understanding and treatment of retinal and vitreous diseases but also aims to inspire future studies in this critical area of eye health.

CURRENT EYE RESEARCH

Elevating Knowledge in Ophthalmology and Beyond
Publisher: TAYLOR & FRANCIS INCISSN: 0271-3683Frequency: 12 issues/year

CURRENT EYE RESEARCH is a prestigious academic journal published by Taylor & Francis Inc, focusing on advancing the field of ophthalmology and its intersection with cellular and molecular neuroscience. Since its inception in 1981, this journal has provided a vital platform for original research, reviews, and technical notes, presenting a wealth of knowledge to practitioners and researchers alike. With an impressive 2023 impact factor reflected in its ranking of Q2 in Ophthalmology and Q2 in Sensory Systems, and a Q3 ranking in Cellular and Molecular Neuroscience, CURRENT EYE RESEARCH plays a crucial role in fostering interdisciplinary collaboration and innovation. The journal is indexed in Scopus, where it holds strong positions in both the Medicine and Neuroscience categories, enhancing its visibility and reach. Researchers and professionals in these fields can access cutting-edge findings and contribute to the ongoing discourse surrounding eye health, making it an essential resource for anyone invested in advancing knowledge and treatment in ophthalmic science.

Augenheilkunde Up2date

Transforming Research into Practice in Ophthalmology.
Publisher: GEORG THIEME VERLAG KGISSN: 1616-9719Frequency: 4 issues/year

Augenheilkunde Up2date is a pivotal journal in the field of ophthalmology, published by GEORG THIEME VERLAG KG, a renowned publisher known for its commitment to advancing medical knowledge. With its ISSN 1616-9719 and E-ISSN 1616-9735, this journal serves as a vital resource for researchers, professionals, and students interested in the latest developments and nuanced discussions in eye health. Although not available as open access, its curated content offers significant insights into contemporary research, clinical practices, and emerging trends in ophthalmology, thus promoting the continuous professional development of its readers. There is an emphasis on providing comprehensive reviews that encapsulate the pertinent advancements in the field, making it an essential publication for those aiming to enhance their expertise in eye care and vision science.

ARQUIVOS BRASILEIROS DE OFTALMOLOGIA

Elevating the standards of ophthalmology through shared knowledge.
Publisher: CONSEL BRASIL OFTALMOLOGIAISSN: 0004-2749Frequency: 6 issues/year

ARQUIVOS BRASILEIROS DE OFTALMOLOGIA is a prominent peer-reviewed journal dedicated to the field of ophthalmology, published by CONSEL BRASIL OFTALMOLOGIA since its inception in 1945. With its commitment to disseminating high-quality research, the journal has transitioned to an Open Access model since 2001, ensuring that vital findings in ophthalmology are freely available to researchers, clinicians, and students alike. Located in São Paulo, Brazil, this esteemed publication occupies a significant position in the medical field, currently holding a Q3 ranking in both the miscellaneous medicine and ophthalmology categories. Although it maintains a legacy of fluctuating impact, recognized for its contribution to the academic community, ARQUIVOS BRASILEIROS DE OFTALMOLOGIA continues to attract a diverse international readership, making it a valuable resource for advancements in eye health, surgical techniques, and ocular research.

SURVEY OF OPHTHALMOLOGY

Transforming Insights into Clinical Practice
Publisher: ELSEVIER SCIENCE INCISSN: 0039-6257Frequency: 6 issues/year

SURVEY OF OPHTHALMOLOGY is a premier journal published by Elsevier Science Inc, dedicated to advancing knowledge in the field of ophthalmology. With an impact factor reflective of its high-quality research—ranking 7th out of 137 in the Scopus category for medicine and ophthalmology, this journal maintains a prestigious Q1 categorization in its field for 2023. Since its inception in 1956, the journal has provided comprehensive reviews and original articles covering various aspects of ophthalmic research and clinical practice, supporting the ongoing education of researchers, professionals, and students alike. While open access options are not available, the journal remains an essential resource for the latest developments, discoveries, and expert insights that shape the future of eye health. Based in the United States, at STE 800, 230 Park Ave, New York, NY 10169, the journal continues a legacy of excellence in ophthalmology until 2024 and beyond, making it a pivotal element of scholarly discourse in this vital medical discipline.

Seminars in Ophthalmology

Advancing the Frontiers of Vision Science
Publisher: TAYLOR & FRANCIS INCISSN: 0882-0538Frequency: 6 issues/year

Seminars in Ophthalmology is a prestigious journal published by Taylor & Francis Inc, dedicated to advancing knowledge in the field of ophthalmology and related medical areas. Established in 1986, this journal has consistently provided a platform for high-quality research and insights, supporting the community with its impactful publications. With an impressive ranking of #55 out of 137 in the Ophthalmology category, the journal currently holds a Q2 quartile in both ophthalmology and miscellaneous medicine as of 2023, reflecting its significant contribution to the discipline. Researchers and practitioners can access a wealth of information covering a comprehensive range of topics, bolstering both clinical practice and academic inquiry. While not an open-access publication, Seminars in Ophthalmology remains a crucial resource for advancing ophthalmic research, fostering collaboration, and disseminating valuable findings in a rapidly evolving specialty.

EYE

Illuminating the Frontiers of Vision and Sensory Science
Publisher: SPRINGERNATUREISSN: 0950-222XFrequency: 12 issues/year

EYE is a prestigious peer-reviewed journal published by SpringerNature that serves as a cornerstone in the fields of Ophthalmology, Arts and Humanities, and Neuroscience. Since its inception in 1987, this influential journal has consistently maintained a Q1 Quartile ranking across multiple categories, showcasing its commitment to advancing knowledge and research in its disciplines. With a notable impact factor and a robust Scopus ranking—19th in Ophthalmology and 8th in Sensory Systems—EYE is vital for researchers, clinicians, and students alike, providing a platform for groundbreaking studies and critical reviews. While the journal operates under a subscription model, it ensures broad access to high-quality research, facilitating the dissemination of knowledge that shapes the future of eye health and sensory systems. With an address at Campus, 4 Crinan St, London N1 9XW, England, EYE continues to be a leading light in the understanding and advancement of visual health and sensory sciences.

Saudi Journal of Ophthalmology

Empowering Practitioners: Elevating Standards in Ophthalmology
Publisher: WOLTERS KLUWER MEDKNOW PUBLICATIONSISSN: 1319-4534Frequency: 4 issues/year

Saudi Journal of Ophthalmology, published by Wolters Kluwer Medknow Publications, stands as a crucial platform for the dissemination of innovative research and clinical practices in the field of ophthalmology. Since its inception in 2009, this journal has effectively contributed to the growing body of knowledge with a focus on addressing the diverse visual health challenges faced globally. With an ISSN of 1319-4534 and a E-ISSN of 2542-6680, the journal is indexed in Scopus, where it ranks in the Q3 category of ophthalmology, reflecting its commitment to quality research despite the competitive landscape. Situated in India, it provides a unique regional perspective while facilitating global discourse among researchers, practitioners, and students in ophthalmological sciences. Although it currently does not operate as an open-access journal, the Saudi Journal of Ophthalmology is essential for those aiming to expand their understanding of advancements in eye care, making it a valuable resource for professionals dedicated to enhancing patient outcomes through informed research and clinical practice.

International Journal of Ophthalmology

Transforming Eye Health Through Open Access Insights
Publisher: IJO PRESSISSN: 2222-3959Frequency: 12 issues/year

The International Journal of Ophthalmology, with ISSN 2222-3959 and E-ISSN 2227-4898, is a premier open-access publication dedicated to advancing the field of ophthalmology. Published by IJO PRESS in China, this journal has been a valuable resource since its inception in 2005, providing a platform for groundbreaking research and clinical studies in ophthalmic science. With an impressive Q2 ranking in the 2023 Ophthalmology category and a Scopus rank of #65 out of 137, the journal consistently showcases high-quality articles that contribute significantly to the understanding and treatment of eye diseases. Since adopting an open-access model in 2010, it has expanded its reach, allowing researchers, professionals, and students worldwide to access vital knowledge in the field. The journal aims to bridge the gap between laboratory research and clinical practice, making it an essential resource for those committed to improving visual health and advancing ophthalmologic education and innovation.

Ophthalmology Science

Exploring Breakthroughs for Better Patient Outcomes
Publisher: ELSEVIERISSN: 2666-9145Frequency:

Ophthalmology Science is a premier journal published by Elsevier, dedicated to advancing the field of ophthalmology through innovative research and clinical insights. With an impact factor that positions it in the Q1 category of ophthalmology journals, it stands out as a crucial resource for researchers, clinicians, and students alike. The journal, indexed under ISSN 2666-9145, covers a wide array of topics relevant to eye care, encompassing the latest breakthroughs in diagnostics, therapeutics, and surgical techniques. Operating in the United States from its office in Amsterdam, the journal aims to bridge the gap between laboratory findings and clinical applications, contributing to improved patient outcomes globally. The converged years from 2021 to 2024 reflect its commitment to providing timely and impactful research that shapes the future of ophthalmic practice. Make sure to explore the open access options available for wider dissemination of your work and to stay ahead in the evolving landscape of ophthalmology.